News | Nuclear Imaging | November 15, 2018

GE Healthcare Recalls Millennium Nuclear Medicine Systems

Class I recall initiated due to risk of detector detaching and falling; no patient injuries have been reported

GE Healthcare Recalls Millennium Nuclear Medicine Systems

November 15, 2018 — GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top detector detached and fell onto the detector below it. No patient injuries have been reported, although there remains a risk of potential life-threatening bodily harm if the detector were to detach and fall during a patient exam. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.

The Millennium MG, Millennium MC and Millennium Myosight Nuclear Medicine Systems are devices used to take images of a patient’s organs or tissues to help diagnose or treat a health condition or disease. These systems are intended for use as diagnostic imaging devices which allow the user to acquire data for high-resolution, three-dimensional images.

On Sept. 14, 2018, GE Healthcare sent customers an “Urgent Medical Device Correction Letter.” The letter instructed customers to stop using the Millennium MG, Millennium MC, and Millennium Myosight Nuclear Medicine systems until the company could complete a full and free inspection of all systems. On Nov. 6, GE Healthcare reported they had completed inspections on all Millennium MG, Millennium MC and Millennium Myosight Systems and confirmed no related issues were found.

The recall affects a total of 996 devices with the following model/item numbers:

  • NMH817;
  • NMH816;
  • NMH815;
  • NMH814;
  • NMH803;
  • NMH802;
  • NMH801;
  • NMH800;
  • NGS014;
  • NGS012;
  • NGS009;
  • NGS005; and
  • NG00.

All affected devices were manufactured between Jan. 1, 1997 and July 1, 2012, and distributed between Jan. 1, 1997 and Sept. 1, 2018.

  • Manufacturing Dates: January 1, 1997, to July 1, 2012
  • Distribution Dates: January 1, 1997, to September 1, 2018
  • Devices Recalled in the U.S.: 996

GE Healthcare has determined that the incident was caused by an improperly functioning primary motion stopper and a missing mechanical stopper which would limit the detector’s travel beyond its limits during normal operation.

In June 2013,a patient was killed because a portion of a GE Infinia Hawkeye 4 single photon emission computed tomography (SPECT)/computed tomography (CT) scanner fell during the scan at the James J. Peters VA Medical Center in the Bronx, N.Y.  The weight of nuclear imaging cameras are around 1,300 pounds or more due to it being lead-lined, plus additional lead used in the construction of the internal collimation system. This significant weight poses design challenges in these systems because of the fatigue on its supports. It is an issue that all vendors face.

The death prompted the company to initiate a Class I recall of several of its nuclear imaging systems in 2013 so they would be retrofitted with additional support. The recall, which can be read here, was expanded to most of GE’s SPECT/CT systems in July 2013.

Read the article "Patient Killed During Nuclear Imaging Scan."

Healthcare professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Healthcare professionals employed by facilities that are subject to FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.

For more information: www.gehealthcare.com, www.fda.gov

 

Related Content

Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Strategies to help guide nuclear radiology teams at various healthcare systems in 2021 and beyond
Feature | Nuclear Imaging | September 16, 2021 | By Staff of the American Society of Nuclear Cardiology (ASNC)
A year after COVID-19 turned the world upside do
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
New recommendations will help provide more reliable, reproducible results for MRI-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal Radiology

Knee cartilage compartments with anatomic labels implemented in lateral (left side), central (middle), and medial (right side) MRI obtained with an intermediate weighted fat-saturated fast-spin-echo sequence (top row) and a spin-lattice relaxation time constant in rotating frame (T1r) magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots sequence (bottom row, T1r maps). Study was performed without administration of intravenous gadolinium-based contrast material. The lateral femur (LF)/medial femur (MF) and lateral tibia (LT)/medial tibia (MT) can be further divided into subcompartments on the basis of meniscus anatomy according to Eckstein et al. P = patella, T = trochlea.  Chalian et al, Radiology 2021 301; 7 ©RSNA 2021

News | Magnetic Resonance Imaging (MRI) | September 10, 2021
September 10, 2021 — New recommendations will help provide more reliable, reproducible results for...
Insignia Medical Systems, a leading UK-based enterprise imaging provider, announced it has been acquired by Intelerad Medical Systems, a global leader in medical image management solutions. The deal signals an important step in expanding next-generation imaging solutions and resources to help modernise hospital trusts across the UK. 

Getty Images

News | Radiology Business | September 08, 2021
September 8, 2021 — Insignia Medical Systems, a leadi
Gallium-68 from GalliaPharm is used for the preparation of diagnostic imaging drugs in Positron Emission Tomography (PET).
News | PET Imaging | September 03, 2021
September 3, 2021 — Eckert & Ziegler Radiopharma GmbH has successfully submitted an amendment to their Drug Maste
First-of-its-kind, power-assisted Free Motion telescoping column reduces lift force by up to 70 percent to significantly reduce musculoskeletal stress and strain injuries that may occur over the course of an X-ray technologist’s career
News | Digital Radiography (DR) | September 01, 2021
September 1, 2021 — GE Healthcare introduced the...